Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. | J Med Chem | 2023 | 37669040 | PubTator, text mining | PubMed |
| Pharmacogenetic analysis of inter-ethnic variability in the uptake transporter SLCO1B1 gene in Colombian, Mozambican, and Portuguese populations. | BMC Med Genomics | 2023 | 37658350 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Organic Anion Transporting Polypeptide-Mediated Organic Anion Clearance at the Blood-Cerebrospinal Fluid Barrier. | Mol Pharmacol | 2023 | 37652713 | PubTator, text mining | PubMed |
| Effects of CYP3A4 inhibition/induction and OATP inhibition on the pharmacokinetics of atogepant in healthy adults. | Pain Manag | 2023 | 37650778 | PubTator, text mining | PubMed |
| Conferring liver selectivity to a thyromimetic using a novel nanoparticle increases therapeutic efficacy in a diet-induced obesity animal model. | PNAS Nexus | 2023 | 37649581 | PubTator, text mining | PubMed |
| Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants. | Clin Transl Sci | 2023 | 37639334 | PubTator, text mining | PubMed |
| Monocarboxylate Transporter 13 (MCT13/SLC16A13) Functions as a Novel Plasma Membrane Oligopeptide Transporter. | Nutrients | 2023 | 37630718 | PubTator, text mining | PubMed |
| Machine Learning Techniques Applied to the Study of Drug Transporters. | Molecules | 2023 | 37630188 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality. | Life (Basel) | 2023 | 37629602 | PubTator, text mining | PubMed |
| Antibiotics and Lipid-Modifying Agents: Potential Drug-Drug Interactions and Their Clinical Implications. | Pharmacy (Basel) | 2023 | 37624085 | PubTator, text mining | PubMed |
| Interactions of organophosphate flame retardants with human drug transporters. | Ecotoxicol Environ Saf | 2023 | 37597291 | PubTator, text mining | PubMed |
| Phytochemical Properties, Extraction, and Pharmacological Benefits of Naringin: A Review. | Molecules | 2023 | 37570594 | PubTator, text mining | PubMed |
| The Potential of Bile Acids as Biomarkers for Metabolic Disorders. | Int J Mol Sci | 2023 | 37569498 | PubTator, text mining | PubMed |
| Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity. | Pharm Res | 2023 | 37561322 | PubTator, text mining | PubMed |
| Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease. | Front Endocrinol (Lausanne) | 2023 | 37560311 | PubTator, text mining | PubMed |
| Functional genomics in stem cell models: considerations and applications. | Front Cell Dev Biol | 2023 | 37554308 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes. | Sci Rep | 2023 | 37543674 | PubTator, text mining | PubMed |
| METTL14‑mediated RNA methylation in digestive system tumors. | Int J Mol Med | 2023 | 37539726 | PubTator, text mining | PubMed |
| Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters. | Int J Mol Sci | 2023 | 37510996 | PubTator, text mining | PubMed |
Hepatobiliary-phase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review. | Eur Radiol | 2023 | 37470828 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=12